- Home
- MTLS vs OABI Comparison
MTLS vs OABI Comparison
Compare MTLS & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- OABI
- Stock Information
- Founded
- MTLS 1990
- OABI 2012
- Country
- MTLS Belgium
- OABI United States
- Employees
- MTLS N/A
- OABI N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- OABI Health Care
- Exchange
- MTLS Nasdaq
- OABI Nasdaq
- Market Cap
- MTLS 484.4M
- OABI 389.7M
- IPO Year
- MTLS 2014
- OABI N/A
- Fundamental
- Price
- MTLS $5.90
- OABI $3.65
- Analyst Decision
- MTLS Buy
- OABI Strong Buy
- Analyst Count
- MTLS 1
- OABI 4
- Target Price
- MTLS $9.50
- OABI $9.00
- AVG Volume (30 Days)
- MTLS 365.6K
- OABI 569.4K
- Earning Date
- MTLS 02-20-2025
- OABI 03-19-2025
- Dividend Yield
- MTLS N/A
- OABI N/A
- EPS Growth
- MTLS 106.79
- OABI N/A
- EPS
- MTLS 0.24
- OABI N/A
- Revenue
- MTLS $276,182,835.00
- OABI $20,409,000.00
- Revenue This Year
- MTLS $8.48
- OABI N/A
- Revenue Next Year
- MTLS $9.65
- OABI $78.61
- P/E Ratio
- MTLS $25.05
- OABI N/A
- Revenue Growth
- MTLS 4.15
- OABI N/A
- 52 Week Low
- MTLS $4.70
- OABI $3.10
- 52 Week High
- MTLS $9.69
- OABI $6.55
- Technical
- Relative Strength Index (RSI)
- MTLS 28.10
- OABI 53.96
- Support Level
- MTLS $5.70
- OABI $3.61
- Resistance Level
- MTLS $9.69
- OABI $4.02
- Average True Range (ATR)
- MTLS 0.49
- OABI 0.18
- MACD
- MTLS -0.33
- OABI 0.04
- Stochastic Oscillator
- MTLS 5.01
- OABI 58.89
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.